 Home > Active Ingredient News > Blood System > BMJ: Patients with atrial fibrillation or mechanical heart valve implantation do not require anticoagulation and bridging treatment after invasive surgery

BMJ: Patients with atrial fibrillation or mechanical heart valve implantation do not require anticoagulation and bridging treatment after invasive surgery

 Last Update: 2021-06-16
 Source: Internet
 Author: User

Tags

thrombotic ischemic stroke

1 8 tubing

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Patients with atrial fibrillation and mechanical heart valve implantation require continuous anticoagulant therapy, mainly vitamin K antagonists, but due to invasive surgery, patients need to discontinue warfarin treatment

Recently, researchers investigated the safety and effectiveness of postoperative low molecular weight heparin (LMWH) bridging

The study was carried out in 10 clinical centers in Canada and India.

Thrombus myocardial infarction blood vessel

The incidence of major thromboembolism within 90 days was 1.

Studies have concluded that in patients with atrial fibrillation or mechanical heart valve implantation who interrupted warfarin anticoagulation therapy due to surgery, postoperative dalteparin sodium bridging has no significant effect on preventing the risk of major thrombosis

In patients with atrial fibrillation or mechanical heart valve implantation who discontinued warfarin anticoagulation therapy due to surgery, postoperative dalteparin sodium bridging has no significant effect on preventing the risk of major thrombosis

Original source:

Michael J Kovacs et al.

Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial.

Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Gadusol Powder Gadusol76663-30-4

CAS No.: 76663-30-4

Industrial Grade

$1-1.01/G FOB

Food Additive Iron fumarate for Nutritional Iron Supplements

CAS No.: 141-01-5

Pharmacy Grade

$24-26/G FOB

Aminobenzoic Acid CAS 56-91-7

CAS No.: 56-91-7

Pharmaceutical Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.